GlassScriptPhysician profile
Sheri D Lopez
NPI 1255303897
$10,248.29
in general payments reported to CMS, 2019-2025
39 companies · $741 in 2025
The $741 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $1,219 · 2021: $2,085 · 2022: $1,718 · 2023: $1,795 · 2024: $946 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,481.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,485.45 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,078.21 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,010.58 | 2019-2025 | Uptravi, Opsumit |
| Pfizer INC. | $938.08 | 2019-2025 | |
| Abbott Laboratories | $639.56 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Cardiomems |
| Novo Nordisk INC | $626.75 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $491.81 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $395.82 | 2019-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $393.81 | 2021-2023 | |
| United Therapeutics Corporation | $359.11 | 2019-2024 | Tyvaso |
| Esperion Therapeutics, INC. | $334.21 | 2020-2024 | Nexletol |
| Boston Scientific Corporation | $274.13 | 2021-2024 | Bodyguardian, Watchman Flx |
| Amgen INC. | $264.27 | 2019-2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $201.15 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.43 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $164.91 | 2023-2024 | Inspire |
| Alnylam Pharmaceuticals INC. | $132.21 | 2021-2024 | Amvuttra, Onpattro |
| Amarin Pharma, INC. | $130.36 | 2019-2022 | |
| Atricure, INC. | $125.82 | 2023 | |
| Daiichi Sankyo INC. | $116.13 | 2023-2024 | Injectafer |
| Cvrx, INC. | $114.28 | 2021-2025 | Barostim Neo System |
| Bracco Diagnostics INC. | $103.61 | 2025 | |
| Gilead Sciences, INC. | $87.73 | 2019 | |
| Ge Healthcare | $85.77 | 2023 | Giraffe Omnibed Carestation |
| Lantheus Medical Imaging, INC. | $78.08 | 2021-2022 | |
| Lundbeck LLC | $60.52 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $52.88 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $52.78 | 2022-2025 | Winrevair, Verquvo |
| Scpharmaceuticals INC. | $39.36 | 2024-2025 | |
| Abiomed | $39.31 | 2023 | Impella |
| Astellas Pharma US INC | $39.10 | 2019 | |
| Irhythm Technologies, INC. | $32.34 | 2020-2023 | Zio Xt Patch |
| Regeneron Healthcare Solutions, INC. | $24.65 | 2019 | |
| Innovation Technologies INC | $22.18 | 2024 | Irrisept |
| Philips North America LLC | $18.39 | 2022 | |
| Shockwave Medical, INC | $14.31 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $13.51 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.00 | 2022 | |
| Medtronic USA, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheri Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.